BOLT
Bolt Biotherapeutics Inc
Price:  
0.57 
USD
Volume:  
289,827.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BOLT WACC - Weighted Average Cost of Capital

The WACC of Bolt Biotherapeutics Inc (BOLT) is 4.9%.

The Cost of Equity of Bolt Biotherapeutics Inc (BOLT) is 6.20%.
The Cost of Debt of Bolt Biotherapeutics Inc (BOLT) is 5.00%.

Range Selected
Cost of equity 4.70% - 7.70% 6.20%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 4.2% - 5.7% 4.9%
WACC

BOLT WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.18 0.51
Additional risk adjustments 0.0% 0.5%
Cost of equity 4.70% 7.70%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 4.2% 5.7%
Selected WACC 4.9%